Sk Biopharmaceutica (Korea) Analysis
| 326030 Stock | 103,800 500.00 0.48% |
Sk Biopharmaceuticals Co is overvalued with Real Value of 90069.0 and Hype Value of 103800.0. The main objective of Sk Biopharmaceutica stock analysis is to determine its intrinsic value, which is an estimate of what Sk Biopharmaceuticals Co is worth, separate from its market price. There are two main types of Sk Biopharmaceutica's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Sk Biopharmaceutica's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Sk Biopharmaceutica's stock to identify patterns and trends that may indicate its future price movements.
The Sk Biopharmaceutica stock is traded in Korea on Korea Stock Exchange, with the market opening at 09:00:00 and closing at 15:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Sk Biopharmaceutica's ongoing operational relationships across important fundamental and technical indicators.
326030 |
326030 Stock Analysis Notes
About 64.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 117.74. Sk Biopharmaceuticals had not issued any dividends in recent years. For more info on Sk Biopharmaceuticals Co please contact Dong Lee at 82 31 8093 0114 or go to https://www.skbp.com.Sk Biopharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Sk Biopharmaceutica's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Sk Biopharmaceuticals Co or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Sk Biopharmaceutica generates negative cash flow from operations | |
| About 64.0% of the company shares are owned by insiders or employees |
326030 Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 5.32 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sk Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Sk Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.326030 Profitablity
Sk Biopharmaceutica's profitability indicators refer to fundamental financial ratios that showcase Sk Biopharmaceutica's ability to generate income relative to its revenue or operating costs. If, let's say, Sk Biopharmaceutica is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Sk Biopharmaceutica's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Sk Biopharmaceutica's profitability requires more research than a typical breakdown of Sk Biopharmaceutica's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11. Technical Drivers
As of the 28th of December, Sk Biopharmaceutica owns the Standard Deviation of 2.87, mean deviation of 2.15, and Risk Adjusted Performance of (0.01). Sk Biopharmaceuticals Co technical analysis provides you with a way to harness past data patterns to determine a pattern that measures the direction of the company's future prices.Sk Biopharmaceuticals Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sk Biopharmaceutica middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sk Biopharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Sk Biopharmaceutica Outstanding Bonds
Sk Biopharmaceutica issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sk Biopharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 326030 bonds can be classified according to their maturity, which is the date when Sk Biopharmaceuticals Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Sk Biopharmaceutica Predictive Daily Indicators
Sk Biopharmaceutica intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sk Biopharmaceutica stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.033 | |||
| Daily Balance Of Power | 0.1429 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 104350.0 | |||
| Day Typical Price | 104167.0 | |||
| Market Facilitation Index | 3500.0 | |||
| Price Action Indicator | (300.00) | |||
| Period Momentum Indicator | 500.0 |
Sk Biopharmaceutica Forecast Models
Sk Biopharmaceutica's time-series forecasting models are one of many Sk Biopharmaceutica's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sk Biopharmaceutica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Sk Biopharmaceutica to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Complementary Tools for 326030 Stock analysis
When running Sk Biopharmaceutica's price analysis, check to measure Sk Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sk Biopharmaceutica is operating at the current time. Most of Sk Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sk Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sk Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sk Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |